山东沃华医药科技股份有限公司2025年度业绩预告

Group 1 - The company expects a positive net profit for the year 2025, with an increase of over 50% compared to the previous period [1] - The performance forecast period is from January 1, 2025, to December 31, 2025 [1] - The data for the performance forecast has been communicated with the auditing firm, and there are no discrepancies reported [1][2] Group 2 - The company has implemented a detailed management strategy focusing on cost reduction, sales increase, efficiency improvement, and cash flow enhancement [2] - Marketing reforms have strengthened the sales team, which is now more professional and mature, adapting to market competition [2] - The company has developed a dual-channel sales strategy, effectively covering both hospital and external markets, leading to initial scale in external market sales [2]